Bridgefront Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,528
| Closed | -$619K | – | 725 |
|
|
2025
Q1 | $619K | Sell |
20,528
-1,274
| -6% | -$38.4K | 0.18% | 195 |
|
|
2024
Q4 | $762K | Buy |
21,802
+10,606
| +95% | +$371K | 0.26% | 111 |
|
|
2024
Q3 | $449K | Buy |
11,196
+5,637
| +101% | +$226K | 0.17% | 203 |
|
|
2024
Q2 | $265K | Buy |
+5,559
| New | +$265K | 0.11% | 333 |
|
|
2023
Q4 | – | Sell |
-4,948
| Closed | -$224K | – | 461 |
|
|
2023
Q3 | $224K | Buy |
+4,948
| New | +$224K | 0.16% | 296 |
|
|
2023
Q2 | – | Sell |
-7,056
| Closed | -$252K | – | 564 |
|
|
2023
Q1 | $252K | Buy |
+7,056
| New | +$252K | 0.15% | 262 |
|
|
2021
Q2 | – | Sell |
-6,798
| Closed | -$306K | – | 748 |
|
|
2021
Q1 | $306K | Buy |
6,798
+1,094
| +19% | +$49.2K | 0.1% | 421 |
|
|
2020
Q4 | $323K | Buy |
+5,704
| New | +$323K | 0.11% | 354 |
|